Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:interleukin-23 subunit p19'
(id=6741724 ; fe=en:interleukin-23 subunit p19 ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1230 creation date=2017-06-22 touchdate=2024-09-17 23:44:06.000)
≈ 44 relations sortantes

  1. en:interleukin-23 subunit p19 -- r_associated #0: 41 / 1 -> en:aspects of radiation effects
    n1=en:interleukin-23 subunit p19 | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=41
  2. en:interleukin-23 subunit p19 -- r_associated #0: 39 / 0.951 -> en:therapeutic use - qualifier
    n1=en:interleukin-23 subunit p19 | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=39
  3. en:interleukin-23 subunit p19 -- r_associated #0: 35 / 0.854 -> en:administration & dosage
    n1=en:interleukin-23 subunit p19 | n2=en:administration & dosage | rel=r_associated | relid=0 | w=35
  4. en:interleukin-23 subunit p19 -- r_associated #0: 35 / 0.854 -> en:antagonists & inhibitors
    n1=en:interleukin-23 subunit p19 | n2=en:antagonists & inhibitors | rel=r_associated | relid=0 | w=35
  5. en:interleukin-23 subunit p19 -- r_associated #0: 35 / 0.854 -> en:bioformation
    n1=en:interleukin-23 subunit p19 | n2=en:bioformation | rel=r_associated | relid=0 | w=35
  6. en:interleukin-23 subunit p19 -- r_associated #0: 35 / 0.854 -> en:interleukin-23 binding activity
    n1=en:interleukin-23 subunit p19 | n2=en:interleukin-23 binding activity | rel=r_associated | relid=0 | w=35
  7. en:interleukin-23 subunit p19 -- r_associated #0: 35 / 0.854 -> en:taxonomic
    n1=en:interleukin-23 subunit p19 | n2=en:taxonomic | rel=r_associated | relid=0 | w=35
  8. en:interleukin-23 subunit p19 -- r_associated #0: 35 / 0.854 -> en:ultrastructure
    n1=en:interleukin-23 subunit p19 | n2=en:ultrastructure | rel=r_associated | relid=0 | w=35
  9. en:interleukin-23 subunit p19 -- r_associated #0: 34 / 0.829 -> en:il23a gene
    n1=en:interleukin-23 subunit p19 | n2=en:il23a gene | rel=r_associated | relid=0 | w=34
  10. en:interleukin-23 subunit p19 -- r_associated #0: 34 / 0.829 -> en:in cerebrospinal fluid
    n1=en:interleukin-23 subunit p19 | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=34
  11. en:interleukin-23 subunit p19 -- r_associated #0: 34 / 0.829 -> en:interleukin-23 subunit alpha
    n1=en:interleukin-23 subunit p19 | n2=en:interleukin-23 subunit alpha | rel=r_associated | relid=0 | w=34
  12. en:interleukin-23 subunit p19 -- r_associated #0: 34 / 0.829 -> en:standards characteristics
    n1=en:interleukin-23 subunit p19 | n2=en:standards characteristics | rel=r_associated | relid=0 | w=34
  13. en:interleukin-23 subunit p19 -- r_associated #0: 34 / 0.829 -> en:supply & distribution
    n1=en:interleukin-23 subunit p19 | n2=en:supply & distribution | rel=r_associated | relid=0 | w=34
  14. en:interleukin-23 subunit p19 -- r_associated #0: 32 / 0.78 -> en:analysis aspect
    n1=en:interleukin-23 subunit p19 | n2=en:analysis aspect | rel=r_associated | relid=0 | w=32
  15. en:interleukin-23 subunit p19 -- r_associated #0: 32 / 0.78 -> en:chemical aspects
    n1=en:interleukin-23 subunit p19 | n2=en:chemical aspects | rel=r_associated | relid=0 | w=32
  16. en:interleukin-23 subunit p19 -- r_associated #0: 32 / 0.78 -> en:chemical synthesis
    n1=en:interleukin-23 subunit p19 | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=32
  17. en:interleukin-23 subunit p19 -- r_associated #0: 32 / 0.78 -> en:contraindications aspect
    n1=en:interleukin-23 subunit p19 | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=32
  18. en:interleukin-23 subunit p19 -- r_associated #0: 32 / 0.78 -> en:drug effect
    n1=en:interleukin-23 subunit p19 | n2=en:drug effect | rel=r_associated | relid=0 | w=32
  19. en:interleukin-23 subunit p19 -- r_associated #0: 32 / 0.78 -> en:in blood
    n1=en:interleukin-23 subunit p19 | n2=en:in blood | rel=r_associated | relid=0 | w=32
  20. en:interleukin-23 subunit p19 -- r_associated #0: 32 / 0.78 -> en:isolation & purification analysis
    n1=en:interleukin-23 subunit p19 | n2=en:isolation & purification analysis | rel=r_associated | relid=0 | w=32
  21. en:interleukin-23 subunit p19 -- r_associated #0: 32 / 0.78 -> en:toxicity aspects
    n1=en:interleukin-23 subunit p19 | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=32
  22. en:interleukin-23 subunit p19 -- r_associated #0: 31 / 0.756 -> en:il23a protein, mouse
    n1=en:interleukin-23 subunit p19 | n2=en:il23a protein, mouse | rel=r_associated | relid=0 | w=31
  23. en:interleukin-23 subunit p19 -- r_associated #0: 31 / 0.756 -> en:in urine
    n1=en:interleukin-23 subunit p19 | n2=en:in urine | rel=r_associated | relid=0 | w=31
  24. en:interleukin-23 subunit p19 -- r_associated #0: 31 / 0.756 -> en:interleukin-12 subunit p40
    n1=en:interleukin-23 subunit p19 | n2=en:interleukin-12 subunit p40 | rel=r_associated | relid=0 | w=31
  25. en:interleukin-23 subunit p19 -- r_associated #0: 31 / 0.756 -> en:metabolic aspects
    n1=en:interleukin-23 subunit p19 | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=31
  26. en:interleukin-23 subunit p19 -- r_associated #0: 31 / 0.756 -> en:poisoning aspects
    n1=en:interleukin-23 subunit p19 | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=31
  27. en:interleukin-23 subunit p19 -- r_associated #0: 30 / 0.732 -> en:physiological aspects
    n1=en:interleukin-23 subunit p19 | n2=en:physiological aspects | rel=r_associated | relid=0 | w=30
  28. en:interleukin-23 subunit p19 -- r_associated #0: 29 / 0.707 -> en:il23a wt allele
    n1=en:interleukin-23 subunit p19 | n2=en:il23a wt allele | rel=r_associated | relid=0 | w=29
  29. en:interleukin-23 subunit p19 -- r_associated #0: 29 / 0.707 -> en:interleukin-23
    n1=en:interleukin-23 subunit p19 | n2=en:interleukin-23 | rel=r_associated | relid=0 | w=29
  30. en:interleukin-23 subunit p19 -- r_associated #0: 29 / 0.707 -> en:interleukin-23 receptor binding activity
    n1=en:interleukin-23 subunit p19 | n2=en:interleukin-23 receptor binding activity | rel=r_associated | relid=0 | w=29
  31. en:interleukin-23 subunit p19 -- r_associated #0: 29 / 0.707 -> en:mechanism of action qualifier
    n1=en:interleukin-23 subunit p19 | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=29
  32. en:interleukin-23 subunit p19 -- r_associated #0: 28 / 0.683 -> en:agonists
    n1=en:interleukin-23 subunit p19 | n2=en:agonists | rel=r_associated | relid=0 | w=28
  33. en:interleukin-23 subunit p19 -- r_associated #0: 28 / 0.683 -> en:il23a protein, rat
    n1=en:interleukin-23 subunit p19 | n2=en:il23a protein, rat | rel=r_associated | relid=0 | w=28
  34. en:interleukin-23 subunit p19 -- r_associated #0: 28 / 0.683 -> en:immunology aspects
    n1=en:interleukin-23 subunit p19 | n2=en:immunology aspects | rel=r_associated | relid=0 | w=28
  35. en:interleukin-23 subunit p19 -- r_associated #0: 28 / 0.683 -> en:interleukin 23 measurement
    n1=en:interleukin-23 subunit p19 | n2=en:interleukin 23 measurement | rel=r_associated | relid=0 | w=28
  36. en:interleukin-23 subunit p19 -- r_associated #0: 27 / 0.659 -> en:genetic aspects
    n1=en:interleukin-23 subunit p19 | n2=en:genetic aspects | rel=r_associated | relid=0 | w=27
  37. en:interleukin-23 subunit p19 -- r_associated #0: 27 / 0.659 -> en:historical aspects qualifier
    n1=en:interleukin-23 subunit p19 | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=27
  38. en:interleukin-23 subunit p19 -- r_associated #0: 26 / 0.634 -> en:aspects of adverse effects
    n1=en:interleukin-23 subunit p19 | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=26
  39. en:interleukin-23 subunit p19 -- r_associated #0: 26 / 0.634 -> en:cellular secretion
    n1=en:interleukin-23 subunit p19 | n2=en:cellular secretion | rel=r_associated | relid=0 | w=26
  40. en:interleukin-23 subunit p19 -- r_associated #0: 26 / 0.634 -> en:deficiency aspects
    n1=en:interleukin-23 subunit p19 | n2=en:deficiency aspects | rel=r_associated | relid=0 | w=26
  41. en:interleukin-23 subunit p19 -- r_associated #0: 26 / 0.634 -> en:exposure as collected domain
    n1=en:interleukin-23 subunit p19 | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=26
  42. en:interleukin-23 subunit p19 -- r_associated #0: 26 / 0.634 -> en:pharmacokinetic aspects
    n1=en:interleukin-23 subunit p19 | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=26
  43. en:interleukin-23 subunit p19 -- r_associated #0: 20 / 0.488 -> effet d'un médicament
    n1=en:interleukin-23 subunit p19 | n2=effet d'un médicament | rel=r_associated | relid=0 | w=20
  44. en:interleukin-23 subunit p19 -- r_associated #0: 20 / 0.488 -> en:interleukin-23 subunit alpha, human
    n1=en:interleukin-23 subunit p19 | n2=en:interleukin-23 subunit alpha, human | rel=r_associated | relid=0 | w=20
≈ 45 relations entrantes

  1. effet d'un médicament --- r_associated #0: 39 --> en:interleukin-23 subunit p19
    n1=effet d'un médicament | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=39
  2. en:mechanism of action qualifier --- r_associated #0: 37 --> en:interleukin-23 subunit p19
    n1=en:mechanism of action qualifier | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=37
  3. en:drug effect --- r_associated #0: 36 --> en:interleukin-23 subunit p19
    n1=en:drug effect | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=36
  4. en:exposure as collected domain --- r_associated #0: 34 --> en:interleukin-23 subunit p19
    n1=en:exposure as collected domain | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=34
  5. en:il23a protein, mouse --- r_associated #0: 34 --> en:interleukin-23 subunit p19
    n1=en:il23a protein, mouse | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=34
  6. en:physiological aspects --- r_associated #0: 34 --> en:interleukin-23 subunit p19
    n1=en:physiological aspects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=34
  7. en:bioformation --- r_associated #0: 32 --> en:interleukin-23 subunit p19
    n1=en:bioformation | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=32
  8. en:immunology aspects --- r_associated #0: 32 --> en:interleukin-23 subunit p19
    n1=en:immunology aspects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=32
  9. en:il23a gene --- r_associated #0: 30 --> en:interleukin-23 subunit p19
    n1=en:il23a gene | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=30
  10. en:metabolic aspects --- r_associated #0: 30 --> en:interleukin-23 subunit p19
    n1=en:metabolic aspects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=30
  11. en:standards characteristics --- r_associated #0: 30 --> en:interleukin-23 subunit p19
    n1=en:standards characteristics | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=30
  12. en:agonists --- r_associated #0: 29 --> en:interleukin-23 subunit p19
    n1=en:agonists | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=29
  13. en:chemical synthesis --- r_associated #0: 29 --> en:interleukin-23 subunit p19
    n1=en:chemical synthesis | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=29
  14. en:deficiency aspects --- r_associated #0: 29 --> en:interleukin-23 subunit p19
    n1=en:deficiency aspects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=29
  15. en:il23a protein, rat --- r_associated #0: 29 --> en:interleukin-23 subunit p19
    n1=en:il23a protein, rat | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=29
  16. en:in blood --- r_associated #0: 29 --> en:interleukin-23 subunit p19
    n1=en:in blood | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=29
  17. en:contraindications aspect --- r_associated #0: 28 --> en:interleukin-23 subunit p19
    n1=en:contraindications aspect | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=28
  18. en:il23a wt allele --- r_associated #0: 28 --> en:interleukin-23 subunit p19
    n1=en:il23a wt allele | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=28
  19. en:interleukin-12 subunit p40 --- r_associated #0: 28 --> en:interleukin-23 subunit p19
    n1=en:interleukin-12 subunit p40 | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=28
  20. en:therapeutic use - qualifier --- r_associated #0: 28 --> en:interleukin-23 subunit p19
    n1=en:therapeutic use - qualifier | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=28
  21. en:in urine --- r_associated #0: 27 --> en:interleukin-23 subunit p19
    n1=en:in urine | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=27
  22. en:interleukin 23 measurement --- r_associated #0: 27 --> en:interleukin-23 subunit p19
    n1=en:interleukin 23 measurement | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=27
  23. en:interleukin-23 subunit alpha, human --- r_associated #0: 26 --> en:interleukin-23 subunit p19
    n1=en:interleukin-23 subunit alpha, human | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=26
  24. en:pharmacokinetic aspects --- r_associated #0: 26 --> en:interleukin-23 subunit p19
    n1=en:pharmacokinetic aspects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=26
  25. en:taxonomic --- r_associated #0: 25 --> en:interleukin-23 subunit p19
    n1=en:taxonomic | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=25
  26. en:cellular secretion --- r_associated #0: 24 --> en:interleukin-23 subunit p19
    n1=en:cellular secretion | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=24
  27. en:ultrastructure --- r_associated #0: 24 --> en:interleukin-23 subunit p19
    n1=en:ultrastructure | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=24
  28. en:aspects of radiation effects --- r_associated #0: 23 --> en:interleukin-23 subunit p19
    n1=en:aspects of radiation effects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=23
  29. en:historical aspects qualifier --- r_associated #0: 23 --> en:interleukin-23 subunit p19
    n1=en:historical aspects qualifier | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=23
  30. en:interleukin-23 receptor binding activity --- r_associated #0: 23 --> en:interleukin-23 subunit p19
    n1=en:interleukin-23 receptor binding activity | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=23
  31. en:interleukin-23 subunit alpha --- r_associated #0: 23 --> en:interleukin-23 subunit p19
    n1=en:interleukin-23 subunit alpha | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=23
  32. en:toxicity aspects --- r_associated #0: 23 --> en:interleukin-23 subunit p19
    n1=en:toxicity aspects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=23
  33. en:chemical aspects --- r_associated #0: 22 --> en:interleukin-23 subunit p19
    n1=en:chemical aspects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=22
  34. en:genetic aspects --- r_associated #0: 22 --> en:interleukin-23 subunit p19
    n1=en:genetic aspects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=22
  35. en:interleukin-23 --- r_associated #0: 22 --> en:interleukin-23 subunit p19
    n1=en:interleukin-23 | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=22
  36. en:analysis aspect --- r_associated #0: 21 --> en:interleukin-23 subunit p19
    n1=en:analysis aspect | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=21
  37. en:aspects of adverse effects --- r_associated #0: 21 --> en:interleukin-23 subunit p19
    n1=en:aspects of adverse effects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=21
  38. en:in cerebrospinal fluid --- r_associated #0: 21 --> en:interleukin-23 subunit p19
    n1=en:in cerebrospinal fluid | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=21
  39. en:interleukin-23 binding activity --- r_associated #0: 21 --> en:interleukin-23 subunit p19
    n1=en:interleukin-23 binding activity | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=21
  40. en:poisoning aspects --- r_associated #0: 21 --> en:interleukin-23 subunit p19
    n1=en:poisoning aspects | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=21
  41. en:administration & dosage --- r_associated #0: 20 --> en:interleukin-23 subunit p19
    n1=en:administration & dosage | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=20
  42. en:antagonists & inhibitors --- r_associated #0: 20 --> en:interleukin-23 subunit p19
    n1=en:antagonists & inhibitors | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=20
  43. en:isolation & purification analysis --- r_associated #0: 20 --> en:interleukin-23 subunit p19
    n1=en:isolation & purification analysis | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=20
  44. en:supply & distribution --- r_associated #0: 20 --> en:interleukin-23 subunit p19
    n1=en:supply & distribution | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=20
  45. taxinomique --- r_associated #0: 10 --> en:interleukin-23 subunit p19
    n1=taxinomique | n2=en:interleukin-23 subunit p19 | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr